Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems.
about
Is It Time to Rethink the Notion of Carbapenem-Sparing Therapy Against Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bloodstream Infections? A Critical Review.Clinical benefit of ertapenem compared to flomoxef for the treatment of cefotaxime-resistant Enterobacteriaceae bacteremia.Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.
P2860
Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cefmetazole for bacteremia cau ...... ae comparing with carbapenems.
@ast
Cefmetazole for bacteremia cau ...... ae comparing with carbapenems.
@en
type
label
Cefmetazole for bacteremia cau ...... ae comparing with carbapenems.
@ast
Cefmetazole for bacteremia cau ...... ae comparing with carbapenems.
@en
prefLabel
Cefmetazole for bacteremia cau ...... ae comparing with carbapenems.
@ast
Cefmetazole for bacteremia cau ...... ae comparing with carbapenems.
@en
P2093
P2860
P1476
Cefmetazole for bacteremia cau ...... ae comparing with carbapenems.
@en
P2093
Saori Kobayashi
Takahiko Fukuchi
Tatsuya Nakamura
P2860
P2888
P356
10.1186/S12879-016-1770-1
P577
2016-08-18T00:00:00Z
P6179
1051552264